GLP Watchdog

CoreAge Rx vs Fridays

Neither CoreAge Rx nor Fridays has an FDA warning letter on record. On compounded tirzepatide injection, CoreAge Rx costs $2,760 less a year at standing rates: $129 a month against $359 a month at Fridays. It is one of two products the two sell at comparable terms.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

CoreAge Rx / Fridays

Featured pick (affiliate partner)

CoreAge Rx logo

CoreAge Rx

9.0/10

Fridays logo

Fridays

5.8/10

FDA warning letters
None on record
None on record
Pharmacy
None named in our record
Lowest standing price
$79/moCompounded semaglutide injection
$249/moCompounded semaglutide injection
States
48 states
No state list published
Checked
Prices captured Record checked November 2026
Prices captured Record checked October 2026
Visit CoreAge Rx
Visit Fridays

CoreAge Rx is our featured pick on this page because it is an affiliate partner: we are paid if you sign up through our link. Fridays pays us nothing. The scores are computed the same way for both and are shown as computed (CoreAge Rx 9.0, Fridays 5.8). How we are paid

What the record shows

  1. 01

    Neither CoreAge Rx nor Fridays has an FDA warning letter on record.

  2. 02

    Fridays names four pharmacies. CoreAge Rx names no compounding pharmacy in our record.

  3. 03

    On compounded tirzepatide injection, CoreAge Rx costs $2,760 less a year at standing rates: $129 a month against $359 a month at Fridays. It is one of two products the two sell at comparable terms.

  4. 04

    Only Fridays lists a price for brand-name semaglutide pen and brand-name tirzepatide pen.

  5. 05

    CoreAge Rx lists 48 states. Fridays publishes no state list.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

CoreAge Rx

Fridays

Compounded semaglutide injection

$79/moLower

$948 a year

$249/mo

$2,988 a year

Compounded tirzepatide injection

$129/moLower

$1,548 a year

$359/mo

$4,308 a year

Brand-name semaglutide pen
Not sold or not priced

$1,498/mo

$17,976 a year

Brand-name tirzepatide pen
Not sold or not priced

$1,828/mo

$21,936 a year

Price includes
Medication, clinician visits, shipping
Medication, clinician visits, coaching
Cancel any time
Yes, stated
Yes, stated
Minimum term
None
None on the monthly plan; 3, 6 and 12-month plans are prepaid
Refunds
Refund before provider approval, less a $50-$100 consult fee; final once sent to the pharmacy; none after 30 days
Fees are non-refundable except for medical disqualification, billing errors or where the law requires
Early-exit fee
None stated
Not stated

Read off each seller’s own pages. CoreAge Rx: November 5, 2026. Fridays: October 30, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for CoreAge Rx

9.0/10
Featured pick (affiliate partner)
  • $2,040 a year less on compounded semaglutide injection
  • $2,760 a year less on compounded tirzepatide injection
  • Names no compounding pharmacy
Visit CoreAge Rx

The case for Fridays

5.8/10
  • Sells brand-name semaglutide pen and brand-name tirzepatide pen, which CoreAge Rx does not price
  • Names its compounding pharmacy
  • Publishes no state list
Visit Fridays

Scores

CoreAge Rx 9.0 · Fridays 5.8 out of 10. Six weighted parts.

Value25%

10.0A
vs
B
3.4

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
3.0

Trust & Safety15%

7.5A
vs
B
5.5

Accessibility10%

9.7A
vs
B
5.0

Support10%

7.0A
vs
B
7.0

The score is the same formula for every seller. Payment does not enter it. Method

CoreAge Rx vs Fridays: questions

Neither CoreAge Rx nor Fridays has an FDA warning letter on record. Letters are matched to a seller by company, domain and address, never by a similar name.
Fridays names four pharmacies. CoreAge Rx names no compounding pharmacy in our record. A 503A pharmacy compounds for named patients on a prescription; a 503B outsourcing facility is registered with FDA and inspected under federal manufacturing rules.
CoreAge Rx, by $2,040 a year at standing rates. CoreAge Rx: $79 a month, about $948 a year. Fridays: $249 a month, about $2,988 a year.
CoreAge Rx states you can cancel at any time; refunds: refund before provider approval, less a $50-$100 consult fee; final once sent to the pharmacy; none after 30 days. Fridays states you can cancel at any time; refunds: fees are non-refundable except for medical disqualification, billing errors or where the law requires.
CoreAge Rx is our featured pick on this page because it is an affiliate partner: we are paid if you sign up through our link. Fridays pays us nothing. The scores are computed the same way for both and are shown as computed (CoreAge Rx 9.0, Fridays 5.8).

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks